Related Experiment Video
Updated: Jul 16, 2025
00:06
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
Riccardo Carloni1,2, Simone Sabbioni1,2, Alessandro Rizzo3
1Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy.
Journal of Hepatocellular Carcinoma
|September 13, 2023
Summary
Hepatocellular carcinoma (HCC) treatment is advancing with immune checkpoint inhibitors (ICIs). Research focuses on combining ICIs with other immunotherapies like CAR-T cells and vaccines for better outcomes in advanced HCC.
Area of Science:
- Hepatology and Oncology
- Immunotherapy Research
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- Advanced HCC at diagnosis and post-surgery relapse are significant clinical challenges.
Purpose of the Study:
- To review the rationale and ongoing clinical trials for immune-based combination therapies in advanced HCC.
- To explore emerging immunotherapy strategies beyond immune checkpoint inhibitors (ICIs).
Main Methods:
- Review of current literature and clinical trial data on immunotherapy for HCC.
- Focus on combination treatments involving ICIs, CAR-T cells, and anti-cancer vaccines.
Main Results:
- Immune checkpoint inhibitors (ICIs) like atezolizumab/bevacizumab and durvalumab/tremelimumab are established first-line treatments.
- Combination therapies based on ICIs are the primary focus of current research.
Conclusions:
- Combination immunotherapy represents the future direction for advanced HCC treatment.
- Novel strategies including CAR-T cells and vaccines hold promise for improving HCC patient outcomes.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K